NCT07470190 Anatomical Evaluation of Supraspinatus Through Ultrasonography and Biomechanical Measurements Following Different Combinations of Physical Therapies in Patients of Supraspinatus Tendinitis
| NCT ID | NCT07470190 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sehat Medical Complex |
| Condition | Supraspinatus Tendinitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-02-23 |
| Primary Completion | 2026-08-23 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-02-23 with a primary completion date of 2026-08-23.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A randomized controlled trial will be conducted to get the expected outcomes. Patients of both gender groups with unilateral shoulder pain will be selected with age range 40-60 years from Sehat medical complex and randomly allocated into four groups (Group A, B, C and D) of two different trials (Trial I and Trial II). The sample size will be 120 patients for both trials. Musculoskeletal ultrasound, goniometry, pain pressure threshold, dynamometer and functional indices will be used to measure the tendon thickness, range of motion, pain, muscle strength and function level. The group A will get BFRT, Group B will get ESWT, group c will get the combination of both and group D will be the Control group (Routine physical therapy). In Trial II the group A will get BFRT, Group B will get Eccentric Training, Group C will get combination of both A \& B and group D will be control group. data will be collected at baseline, 4th week, 8th week and 12 week of interventions. For data analysis SPSS version 25 will be used. Repeated measures ANOVA will be applied to compare the quantitative data within and between the groups. Post-Hoc test Tukey and Bonferroni correction will be used. The level of significance will be set at 5% (P\<0.05).
Eligibility Criteria
Inclusion Criteria: * unilateral shoulder pain * both gender group * two positive tests of (Neer impingement test, Hawkins-Kendy test, Empty can test), * shoulder pain history up to 3 months * not receiving any physiotherapy last 3 months. * not receiving pain medications (NSAIDS) for last 15 days. Exclusion Criteria: * referred shoulder pain * limited shoulder ROM less then 90 degree * previous shoulder surgery, intra articular injection or nerve block last 6 months. * patient with 180 mmHg blood pressure/uncontrolled BP * upper limb fracture, uncontrolled diabetes, open wounds, fistula and vascular surgery. * pregnant woman or 6 month history of pregnancy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07470190 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 60 Years, studying Supraspinatus Tendinitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07470190 currently recruiting?
Yes, NCT07470190 is actively recruiting participants. Contact the research team at imran.ghafoor64@gmail.com for enrollment information.
Where is the NCT07470190 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07470190 clinical trial?
NCT07470190 is sponsored by Sehat Medical Complex. The trial plans to enroll 60 participants.